17Sep/13

Health Canada approves Aastrom's clinical trial application for heart failure drug – Pharmaceutical Business Review

Health Canada approves Aastrom’s clinical trial application for heart failure drug
Pharmaceutical Business Review
Currently patients are being enrolled in the US to participate in the ixCELL-DCM trial, which is a randomized, double-blind, placebo-controlled study of ixmyelocel-T in patients with advanced heart failure due to ischemic dilated cardiomyopathy (DCM), 
Aastrom (ASTM) Approved Trial Application for P2b Study in CanadaProactive Investors USA & Canada

all 3 news articles »

16Sep/13

Children's Hospital of Philadelphia Becomes First Accredited Pediatric Heart … – PR Newswire (press release)

Children’s Hospital of Philadelphia Becomes First Accredited Pediatric Heart
PR Newswire (press release)
16, 2013 /PRNewswire/ — The Healthcare Accreditation Colloquium announced today that Children’s Hospital of Philadelphia (CHOP) became the first Accredited Pediatric Heart Failure Institute in Pennsylvania and third in the nation following nearly a

and more »

16Sep/13

Former mayor recovering with pacemarker after sudden heart failure – Maidenhead Advertiser


Maidenhead Advertiser

Former mayor recovering with pacemarker after sudden heart failure
Maidenhead Advertiser
The wife of a former mayor has praised the rapid response of emergency services following her husband’s sudden heart failure. Albert ‘Bert’ Bellworthy, Mayor of Maidenhead and Windsor from 1981-82, collapsed on Wednesday, September 4, outside 

13Sep/13

Report Published: "Chronic Heart Failure – Current and Future Players" – SBWire (press release)

Report Published: “Chronic Heart Failure – Current and Future Players”
SBWire (press release)
Boston, MA — (SBWIRE) — 09/13/2013 — GlobalData has released its pharma report, “Chronic Heart Failure – Current and Future Players”. The report is a vital source of up-to-date information with in-depth analysis on the companies in the rapidly

13Sep/13

Just Released: "PharmaPoint: Chronic Heart Failure – France Drug Forecast and … – SBWire (press release)

Just Released: “PharmaPoint: Chronic Heart Failure – France Drug Forecast and
SBWire (press release)
Boston, MA — (SBWIRE) — 09/13/2013 — GlobalData has released its new Country report, “PharmaPoint: Chronic Heart Failure – France Drug Forecast and Market Analysis to 2022″. The chronic heart failure (CHF) market is a mature market that has been 

and more »